Equitable Access to High-Cost Pharmaceuticals

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Business & Finance, Industries & Professions, Industries
Cover of the book Equitable Access to High-Cost Pharmaceuticals by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128119624
Publisher: Elsevier Science Publication: February 27, 2018
Imprint: Academic Press Language: English
Author:
ISBN: 9780128119624
Publisher: Elsevier Science
Publication: February 27, 2018
Imprint: Academic Press
Language: English

Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines.

  • Evaluates impact and efficacy of current access policies and pricing regulation of high-cost drugs
  • Incorporates existing guidelines and recommendations by international organizations
  • Compares and contrasts how different countries fund and police high-cost drug access
  • Explores novel and emergent policies, including managed entry agreement, analysis of real world data and differential pricing
  • Reviews novel pharmaceuticals of current research interest
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines.

More books from Elsevier Science

Cover of the book Handbook of Commercial Policy by
Cover of the book Disasters and Public Health by
Cover of the book Biodiversity and Evolution by
Cover of the book Alkaloids: Chemical and Biological Perspectives by
Cover of the book Pipe Drafting and Design by
Cover of the book Handbook of Computational Geometry by
Cover of the book Quality of Experience Paradigm in Multimedia Services by
Cover of the book Colloidal Organization by
Cover of the book Quantitative Imaging in Cell Biology by
Cover of the book Treatment Planning and Dose Calculation in Radiation Oncology by
Cover of the book Theory and Modeling of Dispersed Multiphase Turbulent Reacting Flows by
Cover of the book Solution Thermodynamics and its Application to Aqueous Solutions by
Cover of the book Advances in Immunology by
Cover of the book Digital Identities by
Cover of the book Bio-Instructive Scaffolds for Musculoskeletal Tissue Engineering and Regenerative Medicine by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy